PRISM Mid-Day Movers: Board Shakeups and Biotech Financings Drive Investor Focus

Stock Information for PLUS THERAPEUTICS Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About PLUS THERAPEUTICS Inc.

Orange Belgium Enriches Distributed Access Architecture Deployment with CommScope's Video Unified Edge
CommScope Stockholders Approve Proxy Proposals
CommScope Reports First Quarter 2025 Results
CommScope to Release First Quarter 2025 Financial Results on May 1
CommScope Deploys vCCAP Evo Platform in Central Europe
CommScope and Altice Labs Combine PON Technologies to Power Next-Gen FTTH Networks
CommScope Announces Propel XFrame Solution for Data Centers
CommScope Reports Fourth Quarter and Full Year 2024 Results

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.